There have been a number of initiatives discussed and started in recent weeks. I have been approached already by a couple of groups to assist in looking at specific actions that could take place. Motives amongst the shareholders varies but all have a goal in wishing to prevent or at least mitigate this type of reprehensible behaviour from repeating itself.
As such, I am garnering details on who wishes to be part of the actions that are being undertaken. We have some folks who require assistance in reporting Xped to ASIC and we also have a group who are looking at legal action.
If you wish to be part of the group or groups that will be taking matters further then please send me an email to j[email protected]. Please treat this matter seriously and provide legitimate contact details along with any thoughts you may have.
Just as a side note, I am happy to assist those on putting together their reports to ASIC. I will be doing same and so can create a template.
Thanks
- Forums
- ASX - By Stock
- OAK
- Xped - Further action
Xped - Further action
-
- There are more pages in this discussion • 508 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OAK (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.619M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9135 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 28474 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9135 | 0.060 |
1 | 100000 | 0.059 |
1 | 82000 | 0.055 |
1 | 55000 | 0.053 |
1 | 100000 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 28474 | 1 |
0.105 | 1524 | 1 |
0.175 | 22450 | 1 |
0.180 | 30000 | 1 |
0.190 | 29137 | 1 |
Last trade - 16.12pm 13/11/2024 (20 minute delay) ? |
Featured News
OAK (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online